Activin Receptor Type-1B: A Potential Drug Target (G91)

Target Name: ACVR1B

NCBI ID: G91

ACVR1B

Activin Receptor Type-1B: A Potential Drug Target

The activin receptor type-1B (isoform c) is a protein that plays a crucial role in various physiological processes in the body. It is a member of the activin receptor tyrosine kinase family, which is a subfamily of the protein tyrosine kinase family. This family is known for their ability to regulate cell proliferation, differentiation, and survival. The activin receptor type-1B is one of the activin receptor isoforms, which means that it is one of the several different forms of the activin receptor protein that exist in the body.

The activin receptor type-1B is involved in a wide range of physiological processes that are important for the development, growth, and maintenance of tissues and organs. It is involved in the regulation of cell proliferation, differentiation, and survival, as well as in the regulation of cell-cell and cell-tissue interactions. It is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

Despite the importance of the activin receptor type-1B in various physiological processes, it is not well understood. There is currently limited research on this protein, and much of its function and significance is still unknown. However, it is possible that the activin receptor type-1B may be a drug target or biomarker, and further research is needed to determine its potential role in human health and disease.

The Activin Receptor Type-1B

The activin receptor type-1B is a protein that is expressed in a wide range of tissues and organs in the body. It is primarily expressed in the brain, where it is involved in the regulation of neural stem cell proliferation and differentiation. It is also expressed in other tissues, including the heart, skeletal muscles, and kidneys.

The activin receptor type-1B is a member of the activin receptor tyrosine kinase family, which is a subfamily of the protein tyrosine kinase family. This family is known for their ability to regulate cell proliferation, differentiation, and survival. The activin receptor type-1B is one of the activin receptor isoforms, which means that it is one of the several different forms of the activin receptor protein that exist in the body.

The activin receptor type-1B is involved in a wide range of physiological processes that are important for the development, growth, and maintenance of tissues and organs. It is involved in the regulation of cell proliferation, differentiation, and survival, as well as in the regulation of cell-cell and cell-tissue interactions. It is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

The activin receptor type-1B is involved in the regulation of several different processes in the body. For example, it is involved in the regulation of cell proliferation and differentiation, which are processes that are important for the growth and development of tissues and organs. It is also involved in the regulation of cell-cell and cell-tissue interactions, which are processes that are important for the proper functioning of cells and tissues.

The activin receptor type-1B is also involved in the regulation of several different signaling pathways. For example, it is involved in the regulation of the TGF-β pathway, which is a signaling pathway that is important for cell proliferation and differentiation. It is also involved in the regulation of the FGF pathway, which is a signaling pathway that is important for cell proliferation and survival.

The Activin Receptor Type-1B as a Drug Target

The activin receptor type-1B is a protein that is involved in a wide range of physiological processes that are important for the development, growth, and maintenance of tissues and organs. As a result, it is a potential drug target, and further research is needed to determine its potential role in human health and disease.

One of the potential benefits of targeting the activin receptor type-1B is that it may be able to

Protein Name: Activin A Receptor Type 1B

Functions: Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating a many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, type-2 receptors (ACVR2A and/or ACVR2B) act as a primary activin receptors whereas the type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor such as ACVR1B. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor. ACVR1B also phosphorylates TDP2

The "ACVR1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACVR1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets